| 摘要 |
The present invention discloses assays to stratify progressive B-cell chronic lymphocytic leukemia (CLL) from stable or stable- progressive forms. An antibody microarray is provided which is specific for 18 or more of following the 27 CD antigens differentially abundant in progressive CLL: CD11a, CD11b, CD11c, CD18, CD19, CD20, (two epitopes), CD21, CD22, CD23, CD24, CD25, CD38, CD40,CD43, CD45, CD45RA, CD52, CD69, CD81, CD84, CD98, CD102, CD148, CD180, CD196 and CD270. |
